Atlas Trials

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

Clinical trial NCT00770458 · COMPLETED

Trial details

NCT number
NCT00770458
Sponsor
Sequenom, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Down Syndrome (Trisomy 21)Edwards Syndrome (Trisomy 18)Patau Syndrome (Trisomy 13)Turner Syndrome
Start date
2008-06-01
Primary completion
2009-10-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.